×

Home Top Podcaster Networks By Language By Country By Category About Us Contact Us Faqs Features News & Blogs Privacy Policy Terms Of Use

☰

Search

Home > This Week in Virology with Vincent Racaniello > TWiV 895: COVID-19 clinical update #112 with Dr. Daniel Griffin


	Podcast:		This Week in Virology with Vincent Racaniello
	Episode:		TWiV 895: COVID-19 clinical update #112 with Dr. Daniel Griffin
	Category:		Religion & Spirituality
	Duration:		00:35:37
	Publish Date:		2022-04-30 04:00:00
	Description:		In COVID-19 clinical update #112, Dr. Griffin reviews seroprevalence of infection-induced antibodies, Moderna filing for vaccine authorization in young children, public health impact of vaccines in US, FDA approval of first treatment for young children, phase 2 data for Sabizabulin, and post infection inflammation. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Seroprevalence of Infection-Induced Antibodies (CDC) Authorization for Vaccine in Young Children Filed (Moderna) Public Health Impact of Vaccines in US (BMJ) FDA authorizes first approved treatment for children (FDA) Phase 2 Data for Sabizabulin (Veru Pharma) Clinical Characteristics of Post Infection Inflammation (The Lancet) Fact Sheet for Providers on Evusheld (FDA) Fact Sheet for Providers on Paxlovid (FDA) Provider Referral for EvuSheld (Northwell Health) Contribute to ASTMH fundraiser at PWB Dr. Griffin’s treatment guide (pdf) Letters read on TWiV 895 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
	Total Play:		0

Some more Podcasts by Vincent Racaniello

30+ Episodes

Urban Agricu .. 30+ 8

200+ Episodes

This Week in .. 30+ 7

100+ Episodes

This Week in .. 7 3

100+ Episodes

Matters Micr ..

90+ Episodes

Infectious D ..